Dysbiosis in the Gut Microbiome of Pembrolizumab‐Treated Non‐Small Lung Cancer Patients Compared to Healthy Controls Characterized Through Opportunistic Sampling
Haris Charalambous(Bank of Cyprus Oncology Center), Άθως Αντωνιάδης(Unknown), Paris Vogazianos(European University Cyprus), Aristos Aristodimou, Paul Costeas(Deakin University), Cameron Brown, Ioannis M. Stylianou(Translational Therapeutics (United States)), Yiorgos Apidianakis(University of Cyprus), Elisavet Papageorgiou(Bank of Cyprus Oncology Center), Elpiniki Nikolaou(Limassol General Hospital), Jianxiang Chi(Center for the Study of Childhood and Adolescence), Kyriaki Katsaounou(University of Cyprus), D Vraxnos, Christos Shammas(Limassol General Hospital)
Cited by 4
Related Papers
Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family
|Journal of Bacteriology|1992|586
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
|Leukemia|2015|258